Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT05619627
PHASE1

Oral Dexmedetomidine in Pediatric MRI

Sponsor: Soroush Merchant

View on ClinicalTrials.gov

Summary

The objective of this preliminary study is to assess the utility of oral dexmedetomidine as the sole sedative agent in pediatric population undergoing MRI.

Official title: Utility of Oral Dexmedetomidine as the Sole Sedative Agent in Pediatric Population Undergoing MRI

Key Details

Gender

All

Age Range

3 Years - 6 Years

Study Type

INTERVENTIONAL

Enrollment

18

Start Date

2026-06-01

Completion Date

2027-09

Last Updated

2026-04-08

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Dexmedetomidine

Participants will receive oral dexmedetomidine as the sole sedative agent for undergoing MRI

DRUG

General Anesthesia (control group)

Participants will receive general anesthesia for their MRI

Locations (1)

Children's Mercy Hospital

Kansas City, Missouri, United States